BMO Provides $35MM Term Loan to Medexus Pharmaceuticals
Medexus Pharmaceuticals entered into a senior secured credit agreement agented by BMO. The credit agreement provides for a $35 million term loan facility and a $3.5 million revolving loan facility for working capital.
March 9, 2023
BMO | Marcel Konrad | Medexus Pharmaceuticals
Ian Koplin